HSD17B13 and hepatocellular carcinoma: Previously reported associations of HCC in the context of ArC with variants of HSD17B13 rs72613567:TA (p=8.95×10−3; OR=0.81 (95% CI 0.69 to 0.95) and APOE rs429358:C (p=5.44×10−3; OR=0.74 (95% CI 0.60 to 0.91) were nominally significant in this study, but did not achieve genome-wide significance in the discovery cohort (online supplemental tables 5 and 7).